Scientists Are Split Over Findings Of Research Integrity Commission

Integrity Commission Author: Billy Goodman Early reaction to a long-awaited report on scientific misconduct finds members of the research community no closer to consensus on the controversial issue than they have been after previous efforts to elucidate the problem. In fact, the portion of the report eliciting the most contentious response has been the panel's definition of research misconduct itself. Richard Horton, editor of the Lancet, the medical journal based in London, calls the new rep

Written byBilly Goodman
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Integrity Commission Author: Billy Goodman

Early reaction to a long-awaited report on scientific misconduct finds members of the research community no closer to consensus on the controversial issue than they have been after previous efforts to elucidate the problem. In fact, the portion of the report eliciting the most contentious response has been the panel's definition of research misconduct itself.

Richard Horton, editor of the Lancet, the medical journal based in London, calls the new report "a superb piece of analysis about the impact of misconduct on the scientific community." But Ralph Bradshaw, president of the Federation of American Societies for Experimental Biology (FASEB) in Washington, D.C., characterizes it as "an attack on American science."

CRITICFASEB president Ralph Bradshaw calls the commission's report "an attack on American science." The 75-page report, "Integrity and Misconduct in Research," was prepared over the course of 18 months and 15 meetings by the congressionally ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies